Fortress Biotech
FBIO
#9387
Rank
ยฃ66.2 M
Marketcap
ยฃ2.13
Share price
-1.73%
Change (1 day)
20.86%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2025 (TTM): -ยฃ68.21 Million

According to Fortress Biotech 's latest financial reports the company's current earnings are ยฃ59.3 Million. In 2024 the company made an earning of -ยฃ90.47 Million, an increase over its 2023 earnings that were of -ยฃ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ68.21 Million-24.6%
2024 -ยฃ90.47 Million-21.6%
2023 -ยฃ0.12 Billion-28.03%
2022 -ยฃ0.17 Billion29.88%
2021 -ยฃ0.13 Billion59.8%
2020 -ยฃ77.25 Million1.17%
2019 -ยฃ76.35 Million-19.84%
2018 -ยฃ95.26 Million28.99%
2017 -ยฃ73.85 Million37.92%
2016 -ยฃ53.55 Million32.31%
2015 -ยฃ40.47 Million164.31%
2014 -ยฃ15.32 Million-45.14%
2013 -ยฃ27.91 Million37.55%
2012 -ยฃ20.29 Million-22.91%
2011 -ยฃ26.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-ยฃ25.56 Million-61.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
ยฃ18.58 M-127.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.36 Million 32.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-ยฃ25.46 Million-61.90%๐Ÿ‡บ๐Ÿ‡ธ USA